We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Quality Chemicals, a pharmaceutical distributor in Uganda, has teamed up with Indian generic drugmaker Cipla, to build a manufacturing facility and produce HIV antiretrovirals (ARVs) in Uganda, according to the Kampala, Uganda-based newspaper The Monitor.
Wyeth will respond this month to Form 483 observations from an FDA reinspection of the company's Guayama, Puerto Rico, manufacturing facility, the firm announced.
The Australian Therapeutic Goods Administration (TGA) has asked sanofi-aventis to add an alcohol use contraindication to the labeling of its insomnia drug Stilnox in response to recent reports of unusual sleep behaviors, the company announced.
Aspen Pharmacare and Tibotec Pharmaceuticals announced they have signed a royalty-free, nonexclusive license agreement under which Aspen will develop and distribute the HIV drug Prezista in Sub-Saharan Africa.
As part of its market study into exclusive pharmaceutical distribution contracts, the UK's Office of Fair Trading (OFT) could launch an investigation into Pfizer's wholesale distribution contract with Unichem.
The recently announced free-trade agreement (FTA) between South Korea and the U.S. will improve the pharmaceutical market in Korea, according to a statement by the Pharmaceutical Research and Manufacturers of America (PhRMA).
Afro Alpine Pharma has started manufacturing artemisinin, which is used to make malaria drugs, at a newly opened $4 million facility in Kabale, Uganda, according to the Kampala-based newspaper New Vision.
Bristol-Myers Squibb (BMS) is cooperating with U.S. trade officials in a new civil probe launched last week related to the patent litigation settlement over generic Plavix, the company said.